Sequential versus nonsequential measurement of density and affinity of dopamine D2 receptors with [11C]raclopride: 2: Effects of DAT inhibitors

Journal of Cerebral Blood Flow and Metabolism

Volumn 26, Issue 1, 2006, Pages 28-37

  Doudet, Doris J ^a   Ruth, Thomas J ^a   Holden, James E ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Binding assay; DA receptors; MLCRA; Raclopride; Scatchard

Indexed keywords

BRASOFENSINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER INHIBITOR; LIGAND; METHAMPHETAMINE; METHYLPHENIDATE; PROTEIN INHIBITOR; RACLOPRIDE C 11; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; RELIABILITY; REPRODUCIBILITY; SIMULATION; THEORETICAL SAMPLE; TIME;

ANIMALS; BRAIN; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG EVALUATION, PRECLINICAL; FEMALE; HETEROCYCLIC COMPOUNDS, 2-RING; LIGANDS; MACACA MULATTA; MALE; METHAMPHETAMINE; MODELS, NEUROLOGICAL; OXIMES; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RECEPTORS, DOPAMINE D2; TIME FACTORS;

EID: 29144482006     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600161     Document Type: Article

References (25)

1. 11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab 17:437-47
2. 11C]raclopride in anesthetized monkeys. In: Molecular and pharmacologic brain imaging with positron emission tomography (Gjedde A, ed), San Diego, CA: Academic Press, 205-9
3. Delforge J, Bottlaender M, Loc'h C, Guenther I, Fuseau C, Bendriem B, Syrota A, Maziere B (1999) Quantitation of extrastriatal D2 receptors using a high-affinity ligand (FLB 457) and the multi-injection approach. J Cereb Blood Flow Metab 19:533-46
4. Delforge J, Pappata S, Millet P, Samson Y, Bendriem B, Jobert A, Crouzel C, Syrota A (1995) Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil and a single experiment protocol. J Cereb Blood Flow Metab 15:284-300
5. Delforge J, Syrota A, Bendriem B (1996) Concept of reaction volume in the in vivo ligand-receptor model. J Nucl Med 37:118-25
6. 11C]raclopride: 1 effects of methamphetamine. J Cereb Blood Flow Metab 23:1489-93
7. Doudet DJ, Holden JE, Jivan S, McGeer EG, Wyatt RJ (2000) In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism. Synapse 38:105-13
8. 11C]raclopride. J Cereb Blood Flow Metab 23:280-4
9. 11C]raclopride. Synapse 44:198-202
10. 11C]raclopride: combined PET-microdialysis studies. J Cereb Blood Flow Metab 17:932-42
11. 2 dopamine receptor binding in the living human brain by PET. Science 231:258-61
12. 2 receptor increase in PET study of schizophrenia. Arch Gen Psychiatry 44:671-2
13. Holden JE, Jivan S, Ruth TJ, Doudet DJ (2002) In vivo receptor assay with multiple ligand concentrations: an equilibrium approach. J Cereb Blood Flow Metab 22:1132-41
14. Ishizu K, Smith DF, Bender D, Danielsen E, Hansen S, Wong DF, Cumming P, Gjedde A (2000) Positron emission tomography of radioligand binding in porcine striatum in vivo: haloperidol inhibition linked to endogenous ligand release. Synapse 38:87-101
15. Ito H, Hietala J, Blomqvist G, Halldin C, Farde L (1998) Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding. J Cereb Blood Flow Metab 18:941-50
16. Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423-52
17. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834-40
18. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15:217-27
19. Pehek EA (1999) Comparison of the effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum. J Pharmacol Exp Ther 289:14-23
20. 11C]raclopride. J Neurol Sci 132:156-61
21. Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660-72
22. See RE, Murray CE (1992) Changes in striatal DA release and metabolism during and after subchronic haloperidol administration in rats. Neurosci lett 142:100-4
23. 11C]raclopride binding in unanesthetized monkeys. Synapse 45: 207-212
24. Tsukada H, Nishiyama S, Kakiuchi T, Hiroyuki O, Sato K, Harada N, Nakanishi S (1999) Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. Brain Res 849:85-96
25. Wong DF, Gjedde A, Wagner HN (1986) Quantification of neuroreceptors in the living human brain. I: irreversible binding. J Cereb Blood Flow Metab 6:137-46